{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:47:52Z","timestamp":1777884472991,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmc.2026.118606","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:12:37Z","timestamp":1772125957000},"page":"118606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitors"],"prefix":"10.1016","volume":"136","author":[{"given":"Wen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongcheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengda","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuben","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118606_bb0005","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118606_bb0010","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113526","article-title":"Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors","volume":"221","author":"Liang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0020","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1021\/acs.jmedchem.0c01454","article-title":"HDAC-Bax multiple ligands enhance Bax-dependent apoptosis in HeLa cells","volume":"63","author":"Liang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0025","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1021\/acs.jmedchem.1c02225","article-title":"Discovery of DNA-targeting HDAC inhibitors with potent antitumor efficacy in vivo that trigger antitumor immunity","volume":"65","author":"Chen","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105965","article-title":"Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin\/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancer","volume":"127","author":"Wu","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0035","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/acs.jmedchem.9b02161","article-title":"Discovery of peptide Boronate derivatives as histone deacetylase and proteasome dual inhibitors for overcoming bortezomib resistance of multiple myeloma","volume":"63","author":"Zhou","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117242","article-title":"Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors","volume":"85","author":"Zhao","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","article-title":"HDAC8: a multifaceted target for therapeutic interventions","volume":"36","author":"Chakrabarti","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2026.118606_bb0050","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acschembio.6b00396","article-title":"HDAC8 Catalyzes the hydrolysis of long chain fatty acyl lysine","volume":"11","author":"Aramsangtienchai","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2026.118606_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle","volume":"489","author":"Deardorff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118606_bb0060","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/me.2009-0441","article-title":"An acetylation switch modulates the transcriptional activity of Estrogen-related receptor \u03b1","volume":"24","author":"Wilson","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bmc.2026.118606_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115594","article-title":"Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?","volume":"258","author":"Amin","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0070","doi-asserted-by":"crossref","first-page":"21568","DOI":"10.1074\/jbc.M117.811026","article-title":"HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides","volume":"292","author":"Casta\u00f1eda","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.exphem.2012.10.012","article-title":"Histone deacetylases inhibitor sodium butyrate inhibits JAK2\/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms","volume":"41","author":"Gao","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bmc.2026.118606_bb0080","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/onc.2012.81","article-title":"Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8","volume":"32","author":"Yan","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2026.118606_bb0085","first-page":"1677","article-title":"Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer","volume":"25","author":"Park","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2026.118606_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.phrs.2018.03.001","article-title":"Structure-activity relationships of HDAC8 inhibitors: non-hydroxamates as anticancer agents","volume":"131","author":"Amin","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2026.118606_bb0095","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acsmedchemlett.6b00239","article-title":"Development of a potent and selective HDAC8 inhibitor","volume":"7","author":"Ingham","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118606_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115907","article-title":"NBM-BMX, an HDAC8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the \u03b2-catenin\/c-Myc\/SOX2 pathway and upregulating p53-mediated MGMT inhibition","volume":"22","author":"Tsai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118606_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6804","article-title":"A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma","volume":"13","author":"Yang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmc.2026.118606_bb0110","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1021\/jm101605z","article-title":"Development of Tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities","volume":"54","author":"Zhang","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0115","doi-asserted-by":"crossref","first-page":"16313","DOI":"10.1021\/acs.jmedchem.2c01132","article-title":"Development of alkylated hydrazides as highly potent and selective class I histone deacetylase inhibitors with T cell modulatory properties","volume":"65","author":"Sun","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0120","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/acs.jmedchem.4c01438","article-title":"Natural derivatives of selective HDAC8 inhibitors with potent antitumor efficacy against breast Cancer","volume":"67","author":"Chen","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0125","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.0c01025","article-title":"Characterization of conformationally constrained benzanilide scaffolds for potent and selective HDAC8 targeting","volume":"63","author":"Hassan","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acs.jmedchem.3c01779","article-title":"Electrophilic MiniFrags revealed unprecedented binding sites for covalent HDAC8 inhibitors","volume":"67","author":"Keeley","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106112","article-title":"Discovery of a 2,6-diarylpyridine-based hydroxamic acid derivative as novel histone deacetylase 8 and tubulin dual inhibitor for the treatment of neuroblastoma","volume":"128","author":"Tang","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111756","article-title":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors","volume":"184","author":"Wolff","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2018.03.002","article-title":"Discovery of \u2013sulfamoyl-hydroxybenzamides as HDAC8 selective inhibitors","volume":"150","author":"Zhao","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0150","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1021\/acs.jmedchem.3c00644","article-title":"Discovery of HDAC6, HDAC8, and 6\/8 inhibitors and development of cell-based drug screening models for the treatment of TGF-\u03b2-induced idiopathic pulmonary fibrosis","volume":"66","author":"Yu","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118606_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114409","article-title":"Azetidin-2-one-based small molecules as dual hHDAC6\/HDAC8 inhibitors: investigation of their mechanism of action and impact of dual inhibition profile on cell viability","volume":"238","author":"Federico","year":"2022","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:26:38Z","timestamp":1777602398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"alternative-id":["S0968089626000623"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118606","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118606"}}